Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
| Actual shortage: | 60 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 283 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-SOLIFENACIN | 5MG | TABLET | Resolved | 2017-09-08 | 2018-05-05 | 21721 |
| PMS-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-12-09 | 2023-01-10 | 177744 |
| PMS-SOLIFENACIN | 5MG | TABLET | Actual shortage | 2023-08-21 | 2025-05-05 | 202582 |
| PMS-SOLIFENACIN | 10MG | TABLET | Actual shortage | 2023-08-21 | 2025-04-25 | 202585 |
| PMS-SOLIFENACIN | 10MG | TABLET | Resolved | 2017-04-20 | 2018-05-05 | 7510 |
| PMS-SOLIFENACIN | 10MG | TABLET | Resolved | 2017-04-20 | 2020-06-10 | 7514 |
| PMS-SOTALOL - 160 MG | 160MG | TABLET | Resolved | 2017-05-02 | 2017-11-17 | 8636 |
| PMS-SOTALOL - 160 MG | 160MG | TABLET | Actual shortage | 2024-08-23 | 2025-01-07 | 235789 |
| PMS-SOTALOL - 160 MG | 160MG | TABLET | Resolved | 2017-12-08 | 2018-02-20 | 32142 |
| PMS-SOTALOL - 160 MG | 160MG | TABLET | Resolved | 2018-03-19 | 2018-05-18 | 43366 |
| PMS-SOTALOL - 80 MG | 80MG | TABLET | Resolved | 2018-01-26 | 2018-04-19 | 37349 |
| PMS-SOTALOL - 80 MG | 80MG | TABLET | Resolved | 2017-04-07 | 2017-11-10 | 6164 |
| PMS-SOTALOL - 80 MG | 80MG | TABLET | Resolved | 2017-05-02 | 2017-11-22 | 8639 |
| PMS-SULFASALAZINE 500MG/TAB USP | 500MG | TABLET | Resolved | 2017-04-04 | 2019-07-11 | 5511 |
| PMS-SULFASALAZINE 500MG/TAB USP | 500MG | TABLET | Resolved | 2017-04-20 | 2018-10-18 | 7517 |
| PMS-SULFASALAZINE 500MG/TAB USP | 500MG | TABLET | Resolved | 2021-11-15 | 2022-03-04 | 149233 |
| PMS-SULFASALAZINE 500MG/TAB USP | 500MG | TABLET | Resolved | 2022-03-18 | 2022-05-25 | 156960 |
| PMS-SULFASALAZINE-E.C. TAB 500MG | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-04-01 | 2022-04-29 | 157763 |
| PMS-SULFASALAZINE-E.C. TAB 500MG | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-15 | 2022-10-24 | 166784 |
| PMS-SULFASALAZINE-E.C. TAB 500MG | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-10-19 | 2019-02-08 | 64835 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |